PubMed COVID-19 Clinical Care

CONCLUSIONS: Clinicians using telemedicine should be aware of the multiple challenges faced by individuals experiencing IPV and take additional steps to ensure their needs are met in a safe way. These results have potentially important clinical and

CONCLUSIONS: Using machine learning clustering we identified and internally validated two clinical COVID-19 phenotypes with distinct treatment/response characteristics consistent with similar two-phenotype models derived in other hospitalized COVID

CONCLUSIONS: This work offers insights on how to address psychosocial functioning through low-intensity interventions delivered by lay personnel. More research is needed to understand the efficacy of this program and how best to engage housestaff in

According to the phenomenon-taking of classified analog, directional solidification can be an excellent approach for international communication of traditional Chinese medicine (TCM) in the context of COVID-19 pandemic. Attitudes toward TCM by

BACKGROUND: Parkinson disease (PD) is a neurodegenerative disease characterized by motor symptoms, such as bradykinesia, and non-motor symptoms, such as fatigue, which can be a particularly disabling feature of the disease.

CONCLUSIONS: Risk factors for severe COVID-19 outcomes were similar throughout pandemic epochs in unvaccinated people with RD. Ongoing efforts, including vaccination, are needed to reduce COVID-19 severity in this population, particularly in those

CONCLUSION: The XGBoost model reported here showed a good prognostic prediction ability for PDCI of COVID-19 survivors during the recovery period. Among the interpretation methods based on the importance of SHAP values, Hb and MVV contributed the

CONCLUSION: There were no significant differences in OS among patients seen in the SCC before and after myGOC, likely related to a ceiling effect. More oncologists had ACP discussions with patients, and patients had lower symptom scores on ESAS after

Ivermectin is an antiparasitic drug that has been used as an alternative for prophylaxis and treatment of COVID-19 infection. The adverse effects from supratherapeutic doses of ivermectin can include non-neurological and neurological symptoms. In

CONCLUSION: The early COVID-19 pandemic may have affected the delay in time from blood culture collection to antibiotic administration. Later, in recurring COVID-19 pandemics, AST intervention eliminated this problem. When a bacterial infection such